Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in Japanese patients with epidermolysis bullosa to evaluate the safety and efficacy of Oleogel-S10. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oleogel-S10

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Epidermolysis Bullosa, Junctional Epidermolysis Bullosa | Phase 3 | Status: RECRUITING